TAT and HIV-associated neurocognitive disorder: Overall, our data suggest that both HIV Tat and cART induce metabolic stress in the microglia, resulting in persistent microglial activation and leading to mitochondrial dysfunction, which could be the underlying mechanism in the neurocognitive impairment observed in HAND patients, both in the untreated HIV patients as well as in the cART suppressed HIV patients.